These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8278587)

  • 1. [Single photon emission tomography (SPECT). Cerebral function diagnosis for the clinical routine. Indications and radiotracers].
    Neidl KF; Hermes M; Voges M; Kujat C; Hagspiel KD
    Radiologe; 1993 Nov; 33(11):603-11. PubMed ID: 8278587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
    Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
    J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT imaging in psychiatry: introduction and overview.
    Weinberger DR
    J Clin Psychiatry; 1993 Nov; 54 Suppl():3-5. PubMed ID: 8270596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123-I-iomazenil-SPECT in patients with focal epilepsies--a comparative study with 99mTc-HMPAO-SPECT, CT and MR.
    Ferstl FJ; Cordes M; Cordes I; Henkes H; Christe W; Eichstädt H; Barzen G; Schmitz B; Hasler PH; Schubiger PA
    Adv Exp Med Biol; 1991; 287():405-12. PubMed ID: 1759618
    [No Abstract]   [Full Text] [Related]  

  • 5. [123I-iomazenil- and 99mTc-HMPAO in the diagnosis of focal epilepsies: a comparison of untreated and treated patients].
    Venz S; Cordes M; Schmitz B; Hierholzer J; Siekmann R; Keske U; Richter W; Eichstädt H; Felix R
    Nuklearmedizin; 1994 Feb; 33(1):1-7. PubMed ID: 8134280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cortical dysplasia as an epileptogenic focus: reduced binding of 123I-iomezanil with barely perceptible 99mTc-HMPAO SPECT].
    Bartenstein P; Lehmenkühler C; Sciuk J; Schuierer G
    Nuklearmedizin; 1992 Aug; 31(4):142-4. PubMed ID: 1325635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-iomazenil: a quantitative study of the central benzodiazepine receptor distribution.
    Haldemann RC; Bicik I; Pfeiffer A; Wieser HG; Hasler PH; Schubiger P; von Schulthess GK
    Nuklearmedizin; 1992 Jun; 31(3):91-7. PubMed ID: 1322533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative evaluation of drug resistant focal epilepsies with 123I-iomazenil SPECT. Comparison with vidio/EEG monitoring and postoperative results].
    Venz S; Cordes M; Straub HB; Hierholzer J; Schröder R; Richter W; Schmitz B; Meencke H; Felix R
    Nuklearmedizin; 1994 Oct; 33(5):189-93. PubMed ID: 7997376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfixation of 99mTc-HMPAO and hypofixation of 123I-iomazenil in acute herpes encephalitis.
    Launes J; Hokkanen L; Nikkinen P; Liewendahl K; Salonen O; Sirén J; Iivanainen M
    Neuroreport; 1995 May; 6(8):1203-6. PubMed ID: 7662908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
    Saur HB; Bartenstein P; Schober O; Oberwittler C; Lerch H; Masur H
    Nuklearmedizin; 1994 Oct; 33(5):184-8. PubMed ID: 7997375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
    Knable MB; Jones DW; Coppola R; Hyde TM; Lee KS; Gorey J; Weinberger DR
    J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of focal epilepsy: a SPECT scanning comparison of 123-I-iomazenil versus HM-PAO.
    Cordes M; Henkes H; Ferstl F; Schmitz B; Hierholzer J; Schmidt D; Felix R
    AJNR Am J Neuroradiol; 1992; 13(1):249-53. PubMed ID: 1317662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopharmaceuticals for brain imaging.
    Saha GB; MacIntyre WJ; Go RT
    Semin Nucl Med; 1994 Oct; 24(4):324-49. PubMed ID: 7817203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application of brain perfusion SPECT imaging to dementia].
    Matsuda H
    Rinsho Hoshasen; 1989 Oct; 34(11):1327-35. PubMed ID: 2601094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional imaging using PET and SPECT in pediatric neurology.
    Messa C; Grana C; Lucignani G; Fazio F
    J Nucl Biol Med (1991); 1994 Mar; 38(1):85-8. PubMed ID: 8075181
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT.
    Devous MD; Payne JK; Lowe JL
    J Nucl Med; 1992 Nov; 33(11):1919-24. PubMed ID: 1432149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional cerebral blood flow imaging: a quantitative comparison of technetium-99m-HMPAO SPECT with C15O2 PET.
    Gemmell HG; Evans NT; Besson JA; Roeda D; Davidson J; Dodd MG; Sharp PF; Smith FW; Crawford JR; Newton RH
    J Nucl Med; 1990 Oct; 31(10):1595-600. PubMed ID: 2120397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nuclear medicine in neurology].
    Léveillé J; Soucy JP
    Union Med Can; 1990; 119(4):168-72. PubMed ID: 2201114
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
    Payne JK; Trivedi MH; Devous MD
    J Nucl Med; 1996 Oct; 37(10):1735-40. PubMed ID: 8862321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenge by the murine brain: multi-pinhole SPECT of 123I-labelled pharmaceuticals.
    Pissarek MB; Oros-Peusquens AM; Schramm NU
    J Neurosci Methods; 2008 Mar; 168(2):282-92. PubMed ID: 18061274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.